Plasma aldosterone levels—augmented in diabetic and hypertension patients and experimental models of diabetes—contribute to the increased expression of inflammatory markers, such as TNF-α, chemotactic protein macrophage, transforming growth factor-beta and IL-1β [18,30,32,33,37]. This evidence concerns the gene IL1B and diabetes mellitus.